Boc-8-Aoc-OH

Boc-8-Aoc-OH is a Boc-protected amino acid derivative featuring an 8-aminooctanoic acid (8-Aoc) side chain protected as a carbamate-bearing building block. The presence of the Boc group provides a protected α-amino functionality commonly used to control reactivity during peptide assembly, while the extended aliphatic chain supports incorporation of a flexible, amine-bearing motif into larger synthetic targets. As a protected amino acid building block, it is primarily used in peptide and peptidomimetic synthesis workflows where downstream functionalization or segment condensation requires a stable, well-defined intermediate.

1. Peptide Segment Building

Boc-8-Aoc-OH is used by peptide synthesis groups to assemble peptide segments that incorporate an 8-aminooctanoic acid motif, leveraging the Boc-protected α-amino group to maintain compatibility with coupling conditions during stepwise assembly. Researchers developing medium-length to complex peptidomimetics often select this type of protected building block to introduce a flexible, aliphatic spacer that can influence overall chain topology and local presentation of functional groups in the final sequence. The derivative format helps streamline procurement for custom peptide manufacturing and academic peptide chemistry, where consistent protected building blocks reduce variability across synthesis batches.

2. Peptidomimetic Linker Incorporation

Boc-8-Aoc-OH supports peptidomimetic and scaffold chemistry programs that require a long, flexible linker element bearing an amino-functional side chain for subsequent derivatization. Medicinal chemistry teams and chemical biology researchers commonly use such amino acid derivatives to create intermediate structures that can be elaborated into amide/urea linkages, salt forms, or attachment points for further conjugation steps. By using a protected α-amino building block, the workflow can focus on controlled downstream modification of the side-chain functionality while keeping the backbone reactive sites managed during synthesis and purification.

3. Pharmaceutical Intermediate Synthesis

Boc-8-Aoc-OH is also employed as a defined chiral/functional amino acid intermediate in the preparation of advanced intermediates for pharmaceutical research chemistry and specialty chemical manufacturing. Process development chemists value protected amino acid derivatives when constructing amine-containing fragments that later undergo coupling, protection/deprotection sequencing, or incorporation into larger heterocycle- or peptide-like structures. In these settings, the Boc-protected form provides a practical handle for controlled reactivity management, enabling reliable intermediate generation for subsequent steps in solution-phase or segment-based synthesis strategies.

4. Custom Peptide Manufacturing

Boc-8-Aoc-OH is used by contract peptide synthesis providers and internal peptide core facilities to support custom sequences that include an 8-aminooctanoic acid unit as a structural element. The protected building block format aligns with standard peptide assembly workflows where reagent consistency and predictable reactivity are critical for repeatability across multiple orders or library members. Teams building peptide libraries or structure-property series often rely on such amino acid derivatives to introduce the same spacer chemistry across variants, improving comparability of downstream analytical readouts and enabling efficient scale-up from milligram to gram-scale synthesis development.

1. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

2. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

3. The spatiotemporal control of signalling and trafficking of the GLP-1R

4. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

5. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I